Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 275 of 1329 entries
View as:

Osteoporosis Research Registry

Phase: N/A Priority: Normal
NCT ID: NCT01223300 Org: User:
Start: 11/30/08 End: 12/31/16 Due: 12/31/17

The OPTIMIZE Study: Optimizing Patient Navigation for Perinatal Care

Phase: N/A Priority: Normal
NCT ID: NCT04261894 Org: User:
Start: 06/23/21 End: 09/30/25 Due: 09/30/26

Improving Mobility After Revascularization in Peripheral Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT06686121 Org: User:
Start: 07/01/25 End: 08/01/32 Due: 08/01/33

Lung Function Decline and Disease Risk From Young Adulthood to Middle Age

Phase: N/A Priority: Normal
NCT ID: NCT02245178 Org: User:
Start: 06/30/15 End: 08/31/18 Due: 08/31/19

Mediators of Atherosclerosis in South Asians Living in America (MASALA) Social Network Study

Phase: N/A Priority: Normal
NCT ID: NCT02268513 Org: User:
Start: 09/30/14 End: 02/28/18 Due: 02/28/19

Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06164275 Org: User:
Start: 02/06/24 End: 12/31/31 Due: 12/31/32

The Effect of Walking on Frailty

Phase: N/A Priority: Normal
NCT ID: NCT03654807 Org: User:
Start: 11/26/18 End: 05/31/24 Due: 05/31/25

Evolution of the Chicago Classification: Bridging Physiology and Mechanics

Phase: N/A Priority: Normal
NCT ID: NCT06883175 Org: User:
Start: 09/01/24 End: 06/30/29 Due: 06/30/30

Optimization of Remotely Delivered Physical Activity Intervention for Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT03131440 Org: User:
Start: 04/24/17 End: 06/17/19 Due: 06/17/20

Creating and Optimizing Mindfulness Measures to Enhance and Normalize Clinical Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT03510117 Org: User:
Start: 07/01/17 End: 07/26/22 Due: 07/26/23

Occult Paroxysmal Atrial Fibrillation in Patients With Non-cardioembolic Ischemic Stroke of Determined Mechanism

Phase: N/A Priority: Normal
NCT ID: NCT01410396 Org: User:
Start: 04/30/10 End: 05/31/13 Due: 05/31/14

Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT00709878 Org: User:
Start: 04/30/08 End: 08/31/10 Due: 08/31/11

Bone Loss, Fractures, and Management of Bone Health in People With Stroke in Managed Rehabilitation Settings

Phase: N/A Priority: Normal
NCT ID: NCT00462683 Org: User:
Start: 07/31/07 End: 12/31/10 Due: 12/31/11

Brain, Brainstem, and Spinal Cord fMRI

Phase: N/A Priority: Normal
NCT ID: NCT02356315 Org: User:
Start: 01/31/15 End: 12/31/15 Due: 12/31/16

Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT01805037 Org: User:
Start: 03/05/13 End: 12/31/18 Due: 12/31/19

ICG to Assess Ovarian Perfusion

Phase: N/A Priority: Normal
NCT ID: NCT03927651 Org: User:
Start: 06/01/19 End: 11/15/22 Due: 11/15/23

Positive Emotions After Acute Coronary Events at Northwestern University

Phase: N/A Priority: Normal
NCT ID: NCT04062383 Org: User:
Start: 02/24/20 End: 03/13/20 Due: 03/13/21

Nilotinib in Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03205488 Org: User:
Start: 10/16/17 End: 09/28/19 Due: 09/28/20

Walking Green: The Effects of Walking in Forested and Urban Areas

Phase: N/A Priority: Normal
NCT ID: NCT03950661 Org: User:
Start: 06/01/16 End: 12/08/17 Due: 12/08/18

Tailored Communication to Reduce Cardiovascular Risk

Phase: N/A Priority: Normal
NCT ID: NCT01286311 Org: User:
Start: 01/31/11 End: 01/31/13 Due: 01/31/14

Olfactory Decision-making and Deprived Sleep

Phase: N/A Priority: Normal
NCT ID: NCT05093413 Org: User:
Start: 01/14/21 End: 05/19/22 Due: 05/19/23

Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL

Phase: N/A Priority: Normal
NCT ID: NCT00734773 Org: User:
Start: 11/30/08 End: - Due: -

Programmed Intermittent Epidural Bolus Time Interval and Injection Volume

Phase: N/A Priority: Normal
NCT ID: NCT00417027 Org: User:
Start: 08/31/06 End: 04/30/09 Due: 04/30/10

PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)

Phase: N/A Priority: Normal
NCT ID: NCT00729365 Org: User:
Start: 07/31/08 End: 06/30/10 Due: 06/30/11

NICU2HOME+: Supporting Illinois Families

Phase: N/A Priority: Normal
NCT ID: NCT04480255 Org: User:
Start: 08/03/20 End: 12/31/24 Due: 12/31/25